EUVIMEDScopri EUVIMED
Crossref

Naturally Occurring Deletions/Insertions in HBV Core Promoter Tend to Decrease in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients during Antiviral Therapy

Yaqin Peng, Baoming Liu, Jinlin Hou, Jian Sun, Ran Hao, Kuanhui Xiang, Ling Yan, Jiangbo Zhang, Hui Zhuang, Tong Li

Antiviral Therapy · 2015-08 · 20 (6) · 623-632

DOI: 10.3851/imp2955 ↗

At a glance

Journal article in Antiviral Therapy, published online on 2014-08-01. Written by Yaqin Peng and 9 co-authors. Institution: Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. Major MEDLINE topics: Gene Expression Regulation, Viral, INDEL Mutation. Cited 35 times so far (Crossref); 31 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Mutations in HBV core promoter (CP) are suggested to affect viral replication and disease progression. We investigated CP deletion/insertion mutations (Del/Ins) in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients before and during antiviral treatment.

Methods

Direct and clone sequencings were used for detection of CP Del/Ins in 12 patients. The dynamic changes of CP Del/Ins were tracked in these cases until week 48 of treatment. The effects of Del/Ins on CP activities and hepatitis B X protein (HBx) were analysed using luciferase assay and sequence comparison, respectively. Furthermore, 292 untreated HBeAg-positive CHB cases were also analysed.

Results

Twelve cases with multi-peak PCR direct sequencing electropherograms at baseline were con-firmed to have CP Del/Ins by clone sequencing, with detection rates varying from 14.8% to 93.3% of clones analysed. Follow-up studies showed the detection rates of CP Del/Ins in patients decreased from 100% (12/12) at baseline to 16.7% (2/12) at week 48 of treatment ( P

Subjects

MeSH terms (MEDLINE)

Gene Expression Regulation, ViralINDEL MutationAdultAlanine TransaminaseAntiviral AgentsAspartate AminotransferasesBase SequenceClone CellsDNA, ViralDisease ProgressionFemaleFollow-Up StudiesGenes, ReporterHepatitis B Core AntigensHepatitis B Surface AntigensHepatitis B e AntigensHepatitis B virusHepatitis B, ChronicHost-Pathogen InteractionsHumansLuciferasesMale

Substances

Antiviral AgentsDNA, ViralHepatitis B Core AntigensHepatitis B Surface AntigensHepatitis B e AntigensTrans-ActivatorsViral Regulatory and Accessory Proteinshepatitis B virus X proteinLuciferasesAspartate Aminotransferases

Authors and institutions

  • Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Cite

APA

Peng, Y., Liu, B., Hou, J., Sun, J., Hao, R., Xiang, K., Yan, L., Zhang, J., Zhuang, H., & Li, T. (2015). Naturally Occurring Deletions/Insertions in HBV Core Promoter Tend to Decrease in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients during Antiviral Therapy. Antiviral Therapy, 20(6), 623-632. https://doi.org/10.3851/imp2955

Vancouver

Peng Y, Liu B, Hou J, Sun J, Hao R, Xiang K, et al. Naturally Occurring Deletions/Insertions in HBV Core Promoter Tend to Decrease in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients during Antiviral Therapy. Antiviral Therapy. 2015;20(6):623-632. doi:10.3851/imp2955

BibTeX
@article{Peng2015,
  author = {Peng, Yaqin and Liu, Baoming and Hou, Jinlin and Sun, Jian and Hao, Ran and Xiang, Kuanhui and Yan, Ling and Zhang, Jiangbo and Zhuang, Hui and Li, Tong},
  title = {Naturally Occurring Deletions/Insertions in HBV Core Promoter Tend to Decrease in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients during Antiviral Therapy},
  journal = {Antiviral Therapy},
  year = {2015},
  volume = {20},
  number = {6},
  pages = {623--632},
  doi = {10.3851/imp2955}
}
Start for free →